Term
| symptom comfort for patients with acute bronchitis |
|
Definition
|
|
Term
| mild-moderate disease in acute bronchitis if bacterial infection is suspected |
|
Definition
| Z-pack 250 or tripack 500 |
|
|
Term
| moderate-severe disease in acute bronchitis if bacterial infection is suspected |
|
Definition
|
|
Term
| preferred treatment for Pertussis |
|
Definition
|
|
Term
| for patients who cannot olerate macrolides for Pertussis (contraindicated in infants <2 months) |
|
Definition
|
|
Term
| Good in vitro activity- no clinical data. used as last resort (Pertussis treatment) |
|
Definition
| Fluroquinolones and Ketolides |
|
|
Term
| Strep pneumonia and H influenza, mycoplasma, chlamydophillia; (atypical), pertussis |
|
Definition
|
|
Term
| Active aggitans Strep pneumonia, H influenza, and mycoplasma, chlamadia, broad spectrum reserved for very sick pts, has activity against pertussis but not standard of care |
|
Definition
|
|
Term
| can be used for strep pneum, h. influenza, no activity for atypical (microplasma chalyophilia, no action against pertussis, beta lactams attack cell wall in bacteria but pertussis doesn't have cell wall to attack) |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Primary immunization in children 6 weeks to < 7 years of age 5 dose series |
|
Definition
|
|
Term
| can be administered regardless of inerval since hte last Td (increased local rxns with shorter interval) |
|
Definition
|
|
Term
| treatment in RSV if lower airway obstruction present ie wheezing (but evidence does not support use) |
|
Definition
|
|
Term
| treatment in RSV that may reduce length of inpatient hospitalization |
|
Definition
|
|
Term
|
Definition
| supportive care (hydration, supplemental oxygen, mechanical ventilation if needed, hypertonic saline) |
|
|
Term
| Nuceloside analog, FDA approved for treatment of RSV, routine use not recommended (mixed study results) |
|
Definition
|
|
Term
| RSV immunoglobin used to prevent RSV in premature infants |
|
Definition
|
|
